3859 results for «574»

Filter By

3859 results

TTVR - Part 2

17 Nov 2025 – From PCR London Valves 2025

This session presents advances in transcatheter tricuspid valve replacement (TTVR), highlighting cases such as Evoque valve implantation post-cardioband, TTVR following valve annuloplasty in amyloidosis, rescue interventions after edge-to-edge repair failure, and management of complex anatomical challenges including left inferior vena cava and lead interference in high-risk...

TAVI complications - Part 5

18 Nov 2025 – From PCR London Valves 2025

This session highlights acute and urgent complications following TAVI implantation, including myocardial infarction, cardiac arrest, and challenging catheterization scenarios. It provides detailed case analyses illustrating the limits of TAVI procedures and the critical importance of prompt recognition and intervention in adverse events, enhancing clinician preparedness for...

Featured research - TAVI - Part 11

18 Nov 2025 – From PCR London Valves 2025

This session presents featured research on TAVI, highlighting long-term outcomes and innovations in transcatheter aortic valve therapy. It includes registry data on mild paravalvular leak impact, five-year evaluations of the Hydra THV, comparisons between deep learning and manual echocardiographic assessments, pacemaker implantation outcomes post-TAVI, and procedural...

Featured research - TAVI - Part 14

18 Nov 2025 – From PCR London Valves 2025

This featured research session presents pivotal findings on transcatheter aortic valve implantation (TAVI), including 30-day and one-year outcomes from the VANTAGE trial, novel concepts for assessing aortic stenosis severity, and the influence of mitral annular calcification on conduction disturbances. Additional topics cover the role of clinical...

TAVI: alternative access - Part 2

18 Nov 2025 – From PCR London Valves 2025

This session addresses alternative access routes for TAVI in patients with challenging vascular anatomy. Topics include transapical valve-in-valve procedures complicated by severe aortic regurgitation, percutaneous TAVI via the brachiocephalic trunk, and strategies for managing hostile vascular anatomies. Solutions for scenarios where transfemoral TAVI is not feasible...

Transcatheter solutions for failed mitral TEER

18 Nov 2025 – From PCR London Valves 2025

This session presents innovative transcatheter solutions for managing failed mitral TEER procedures. It highlights advanced closure strategies for inter-clip mitral regurgitation, percutaneous approaches for recurrent mitral regurgitation, novel chordae tendineae replacement techniques, and potential bailout strategies including atrial flow regulation implantation for recurrent heart failure.

TAVI complications - Part 3

18 Nov 2025 – From PCR London Valves 2025

This session provides a detailed examination of TAVI-related complications and their management. Key topics include the STJ-sling technique, valve frame underexpansion diagnosis, real-time intracardiac echocardiography utility, recurrent cardiac arrest scenarios during TAVI, and management strategies for valve in-folding in self-expanding transcatheter valves.

Challenging mitral interventions

18 Nov 2025 – From PCR London Valves 2025

This session explores the complexities of mitral interventions, highlighting advancements and challenges in transcatheter mitral valve repair (TMVR). Topics include the benefits of a simplified single-step TMVR approach, the influence of hemodynamic parameters on MitraClip therapy outcomes, strategies for managing persistent pulmonary oedema, and approaches to...

TAVI complications - Part 4

18 Nov 2025 – From PCR London Valves 2025

This session focuses on complex complications encountered in TAVI procedures, presenting challenging cases such as combined adverse events, wire-related technical difficulties, differential diagnosis between hypoattenuated leaflet thickening and infective endocarditis one year post-TAVI, issues caused by fractured sheath tips impacting valve expansion, and sinus breaches. These...

NIRS-guided PCI: beyond calcium to precision PCI

11 Dec 2025 – From GulfPCR-GIM 2025

This session highlights the utility of Near-Infrared Spectroscopy (NIRS) in guiding precise PCI beyond traditional angiographic assessment. It covers identification of vulnerable lipid-rich plaques, optimization of lesion preparation using atherectomy or lithotripsy when indicated, and improving stent deployment through integrated NIRS and IVUS guidance. Case presentations...

Challenging CTO Interventions - Part 2

11 Dec 2025 – From GulfPCR-GIM 2025

This session addresses the complexities of chronic total occlusion (CTO) interventions with a collection of challenging cases employing advanced techniques. Topics include IVUS-assisted recanalisation, hybrid approaches incorporating 3D wiring, retrograde interventions after antegrade failure, and management of procedural complications such as vessel rupture. The session also...

CTO: retrograde approach

12 May 2021 – From EuroPCR 2021

Watch this session if you wish to learn how to handle biradial retrograde CTO PCI, how to manage minimum contrast retrograde CTO PCI in multiple kidney transplantation patient, how to use the Rendezvous Technique, and more!

EuroPCR 2021 CTO: retrograde approach

HIGHLIFE transseptal mitral valve replacement (TSMVR): step by step

18 May 2021 – From EuroPCR 2021

Watch this session presented by Wolfgang Rottbauer in order to learn about the HighLife transseptal mitral valve replacement procedure, to understand the interaction between the devices and the anatomy and to be familiar with upcoming technologies in structural heart procedures.

HIGHLIFE transseptal mitral valve replacement (TSMVR): step by step

Complete revascularisation in patients with acute myocardial infarction

18 May 2021 – From EuroPCR 2021

Watch this session presented by Piroth Zsolt in order to get a quick update on the latest most significant evidence in physiology guided PCI in patients with acute MI, to have a recommendation from an expert on how this assessment can be implemented today compatibly with a IIa...

Complete revascularisation in patients with acute myocardial infarction

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about...

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

FFR-guided PCI optimisation directed by high-definition IVUS

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the rationale of low post-PCI FFR, to learn if and how post-PCI FFR can be improved, and to know more about the risk of post-PCI optimisation.

FFR-guided PCI optimisation directed by high-definition IVUS

New, novel Navitor TAVI valve with active paravalvular leak-sealing technology

18 May 2021 – From EuroPCR 2021

Watch this session presented by Lars Sondergaard to learn about the latest TAVI active PVL-sealing technology, to understand the clinical evidence with the active PVL-sealing technology, and to discuss the value that the new, novel Navitor valve brings in today's TAVI market.

View the recording of this EuroPCR 2021 Session...

New, novel Navitor TAVI valve with active paravalvular leak-sealing technology

Guiding primary PCI using high-definition intravascular ultrasound

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the pitfalls of primary PCI, to learn how IVUS can improve outcomes, and to understand the importance of plaque and thrombus quantification.

Guiding primary PCI using high-definition intravascular ultrasound

Clinical event reductions in high-risk hypertension patients treated with renal denervation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...

Clinical event reductions in high-risk hypertension patients treated with renal denervation

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes
Didn’t find what you were looking for?